The role of granulocytes in the pulmonary response to group B streptococcal toxin in young lambs.
Marked leukopenia and sequestration of granulocytes in the lung are consistently seen in severe early onset group B streptococcal (GBS) disease in human infants. To investigate the role of granulocytes as potential mediators in the pulmonary pathophysiology of this disease, the effects of intravenously administered GBS type III toxin were studied in young lambs before and after granulocyte depletion with hydroxyurea. Granulocyte depletion markedly reduced the 4-fold increase in total lung resistance and the decrease in dynamic compliance observed after GBS toxin. Granulocyte depletion significantly attenuated the pulmonary hypertension, hypoxemia and increased minute ventilation present during the first phase of the response (0.5-1 h after GBS toxin). It did not significantly alter the increase in body temperature, the marked increase in lung lymph thromboxane B2 concentrations during the first phase or the increase in lung lymph flow and protein clearance during the second phase of the response (3.5-5 h after GBS toxin). The results indicate that granulocytes are involved as mediators of the changes in lung mechanics seen after GBS toxin infusion in young lambs. Granulocytes contribute to the pulmonary hypertension and decrease in arterial oxygenation, but other mediators appear to be responsible for the injury of the vascular endothelium.
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D006098:Granulocytes / Q000502:physiology*; D006918:Hydroxyurea / Q000494:pharmacology; D006976:Hypertension, Pulmonary / Q000503:physiopathology; D007970:Leukopenia / Q000139:chemically induced; D008168:Lung / Q000187:drug effects / Q000503:physiopathology*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*; D012756:Sheep; D013696:Temperature; D013929:Thromboxane B2 / Q000032:analysis
D011135:Polysaccharides, Bacterial; C032263:streptococcal polysaccharide type III group B; D013929:Thromboxane B2; D006918:Hydroxyurea